- Home
- CREV vs NUWE Comparison
CREV vs NUWE Comparison
Compare CREV & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CREV | NUWE |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1M | 2.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CREV | NUWE |
|---|---|---|
| Price | $2.53 | $2.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 141.7K | 40.7K |
| Earning Date | 01-30-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $47,677,475.00 | $8,167,999.00 |
| Revenue This Year | $40.32 | N/A |
| Revenue Next Year | N/A | $10.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 86.77 | N/A |
| 52 Week Low | $1.48 | $2.01 |
| 52 Week High | $9.45 | $70.14 |
Technical Indicators
Market Signals| Indicator | CREV | NUWE |
|---|---|---|
| Relative Strength Index (RSI) | 56.65 | 38.24 |
| Support Level | $1.57 | $2.02 |
| Resistance Level | $1.77 | $2.20 |
| Average True Range (ATR) | 0.30 | 0.17 |
| MACD | 0.12 | -0.01 |
| Stochastic Oscillator | 69.96 | 0.47 |
Price Performance
Historical ComparisonAbout CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.